Evaluation of Ex-PRESS implantation combined with phacoemulsification in primary angle-closure glaucoma.
To evaluate the safety and efficacy of Ex-PRESS (R50) implantation combined with phacoemulsification in primary angle-closure glaucoma (PACG) patients with cataract.Twenty-four eyes of 24 patients with unregulated PACG underwent combined cataract and glaucoma surgery. After phacoemulsification and intraocular lens implantation, the Ex-PRESS (R-50) was inserted into the anterior chamber under a scleral flap. The intraocular pressure (IOP), best corrected visual acuity (BCVA), number of medications, and complications were recorded preoperatively as well as postoperatively on day 7 and at 1, 3, 6, and 12 months.The mean follow-up was 16.4 ± 2.5 months (range 14-21 months) and the mean age of the patients was 64.7 ± 6.8 years (range 56-78 years). The mean IOP was 20.4 ± 5.4 mm Hg preoperatively and decreased to 10.2 ± 2.8, 13.1 ± 2.7, 14.9 ± 4.1, 14.3 ± 3.9, and 14.0 ± 3.6 mm Hg on day 7 and at 1, 3, 6, and 12 months after surgery (all P < 0.005). At 12 months, the mean BCVA was 0.62 ± 0.33 and the number of medications was 0.3 ± 0.6. Most of complications were resolved spontaneously and conservatively.The Ex-PRESS implantation combined with phacoemulsification cataract extraction is safe and effective for reducing IOP and antiglaucoma medications in PACG patients with cataract.
Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine Eye Institute of Shandong University of Traditional Chinese Medicine Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Bing
B
Liu
Da-Dong
DD
Guo
Xiu-Juan
XJ
Du
Chen-Yang
CY
Cong
Xiao-Hua
XH
Ma
D000368:Aged; D005260:Female; D020327:Glaucoma Drainage Implants; D015812:Glaucoma, Angle-Closure / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D019919:Prosthesis Implantation; D012189:Retrospective Studies